Lnp Delivery Platform
Proprietary LNP Delivery Technology Engineered for Targeted Delivery through High-Throughput Screening and Optimization
Our scientists have designed and synthesized thousands of novel ionizable cationic lipids, which have undergone in vivo evaluation for both safety and efficacy.
1.Procedure
2.Screening for High-efficiency LNP through in vivo Gene Editing
3.PD and Scale-Up
We have established a GMP production platform to support In-house large-scale LNP-mRNA and in vivo gene editing drug manufacture.
GMP Capability
-
Target both liver/non-liver organs, such as spleen and bone marrow, with up to 5 times stronger delivery rates than those of international counterparts
-
Capable of independently producing high-quality LNP-mRNA drugs
-
Strong IP protection with no infringement issues
